Economics of Hope: How Global Collaboration is Reducing the Cost of Rare Disease Research
Innovation in neurology is undeniably expensive, but the cost of *not* treating these conditions is even higher when considering hospital stays, lost wages, and the physical toll on families. To combat the financial barriers to entry, a new model of "collaborative science" is emerging. Governments, non-profits, and private investors are pooling their resources to fund large-scale "accelerators"...
0 Комментарии 0 Поделились 15 Просмотры 0 предпросмотр
Cryell https://cryell.com